Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-12-003669
Filing Date
2012-01-25
Accepted
2012-01-25 17:59:17
Documents
1
Period of Report
2012-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2244
  Complete submission text file 0001140361-12-003669.txt   3692
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Issuer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA LUIGI SETTEMBRINE 18/A SAN MARIANO CORTIANO PERUGIA L6 06070
Business Address
Binder Offer (Reporting) CIK: 0001539954 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54586 | Film No.: 12545702